cells Article Myxobacteria-Derived Outer Membrane Vesicles: Potential Applicability Against Intracellular Infections Adriely Goes 1,2 , Philipp Lapuhs 1,2 , Thomas Kuhn 1,2, Eilien Schulz 1,2 , Robert Richter 2,3 , Fabian Panter 4 , Charlotte Dahlem 5, Marcus Koch 6, Ronald Garcia 4, Alexandra K. Kiemer 5 , Rolf Müller 2,4,7 and Gregor Fuhrmann 1,2,* 1 Helmholtz Centre for Infection Research (HZI), Biogenic Nanotherapeutics Group (BION), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, 66123 Saarbrücken, Germany;
[email protected] (A.G.);
[email protected] (P.L.);
[email protected] (T.K.);
[email protected] (E.S.) 2 Department of Pharmacy, Saarland University, Campus Building E8.1, 66123 Saarbrücken, Germany;
[email protected] (R.R.);
[email protected] (R.M.) 3 Helmholtz Centre for Infection Research (HZI), Department of Drug Delivery (DDEL), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, 66123 Saarbrücken, Germany 4 Helmholtz Centre for Infection Research (HZI), Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, 66123 Saarbrücken, Germany;
[email protected] (F.P.);
[email protected] (R.G.) 5 Department of Pharmacy, Pharmaceutical Biology, Saarland University, 66123 Saarbrücken, Germany;
[email protected] (C.D.);
[email protected] (A.K.K.) 6 INM-Leibniz Institute for New Materials, Campus D2 2, 66123 Saarbrücken, Germany;
[email protected] 7 German Center for Infection Research (DZIF), 38124 Braunschweig, Germany * Correspondence:
[email protected]; Tel.: +49-68-198-806 (ext.